These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 6131432
21. Structure-activity correlation of flavonoids for inhibition of bovine lens aldose reductase. Iinuma M, Tanaka T, Mizuno M, Katsuzaki T, Ogawa H. Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1813-5. PubMed ID: 2509087 [Abstract] [Full Text] [Related]
24. [The characteristics of aldose reductase in human lens, placenta, and rat organs (author's transl)]. Yoshida H. Nippon Ganka Gakkai Zasshi; 1981 Aug 10; 85(8):865-9. PubMed ID: 6797273 [No Abstract] [Full Text] [Related]
25. Inhibition of aldose reductases from rat and bovine lenses by flavonoids. Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M. Biochem Pharmacol; 1982 Dec 01; 31(23):3807-22. PubMed ID: 6818971 [Abstract] [Full Text] [Related]
26. Inhibition of rat lens aldose reductase by bendazac-L-lysine salt. Iuliano G, Menzione M, Apponi-Battini G, Costagliola C. Enzyme; 1989 Dec 01; 42(4):235-7. PubMed ID: 2517113 [Abstract] [Full Text] [Related]
27. Kinetic mechanism and structural properties of lens aldose reductase. Doughty CC, Lee SM, Conrad S, Schade S. Prog Clin Biol Res; 1982 Dec 01; 114():223-42. PubMed ID: 6819583 [No Abstract] [Full Text] [Related]
28. Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives. Inagaki K, Miwa I, Yashiro T, Okuda J. Chem Pharm Bull (Tokyo); 1982 Sep 01; 30(9):3244-54. PubMed ID: 6816474 [No Abstract] [Full Text] [Related]
29. [Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens]. Tanimoto T, Fukuda H, Kawamura J. Yakugaku Zasshi; 1984 Jun 01; 104(6):631-4. PubMed ID: 6438300 [No Abstract] [Full Text] [Related]
34. Synthesis and rat lens aldose reductase inhibitory activity of some benzopyran-2-ones. Brubaker AN, DeRuiter J, Whitmer WL. J Med Chem; 1986 Jun 01; 29(6):1094-9. PubMed ID: 3086557 [Abstract] [Full Text] [Related]
35. Lens aldose reductase in diabetic and galactosemic cataracts. Parmar NS, Ghosh MN. Indian J Physiol Pharmacol; 1981 Jun 01; 25(3):193-200. PubMed ID: 6795119 [No Abstract] [Full Text] [Related]
36. Optical spectroscopy as an in vitro method to monitor aldose reductase inhibitors in the lens. Lerman S, Megaw J, Gardner K. Invest Ophthalmol Vis Sci; 1983 Nov 01; 24(11):1505-10. PubMed ID: 6417041 [Abstract] [Full Text] [Related]
39. Altering the course of cataracts in diabetic rats. Fukushi S, Merola LO, Kinoshita JH. Invest Ophthalmol Vis Sci; 1980 Mar 01; 19(3):313-5. PubMed ID: 6766909 [Abstract] [Full Text] [Related]
40. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors. Jacobson M, Sharma YR, Cotlier E, Hollander JD. Invest Ophthalmol Vis Sci; 1983 Oct 01; 24(10):1426-9. PubMed ID: 6413448 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]